Dr. Dudeja is Professor with tenure, James P Hayes Endowed Professor and Director of Division of Surgical Oncology at University of Alabama at Birmingham. Dr. Dudeja’s clinical practice is focused on taking care of patients with hepato-pancreato-biliary benign and malignant diseases. His research efforts are inspired by the patients that he cares for in his clinical practice. In the area of oncology, Dr. Dudeja’s laboratory focuses on deciphering the biology of tumor microenvironment in pancreatic cancer and exploring the interplay between gut microbiome and anti-cancer immune responses. In the field of pancreatitis, he focuses on advancing innovative treatments for this morbid disease. Currently, he is the initiating PI on two multi-site clinical trials evaluating novel drugs in patients with pancreatitis. Elucidation of the mechanism and determinants of tumor recurrence is another key area studied in his laboratory. His research efforts area funded by grants from National Institutes of Health (NIH), Veterans Affairs, Department of Defense and various Society Grants. His work has been published in various high impact journals such as Gastroenterology, GUT, Clinical Cancer Research, JCI insight and Nature Reviews in Gastroenterology and Hepatology. He serves on the editorial board of Gastroenterology, Frontiers of Immunology and Pancreatology.